PD-L1/PD-1 Pattern of Expression Within the Bone Marrow Immune Microenvironment in Smoldering Myeloma and Active Multiple Myeloma Patients

Federica Costa(University of Parma), Nicola Giuliani(University of Parma)

Frontiers in Immunology

January 8, 2021

10.3389/fimmu.2020.613007

Cited by 20

Related Papers

Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

|Blood|2016|172

Checkpoint Inhibition in Myeloma: Opportunities and Challenges

|Frontiers in Immunology|2018|62

Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients

|Cancers|2019|35

Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties

|Oncotarget|2017|30

Study of the immune-microenvironment in Multiple Myeloma: understanding the effects of immunomodulatory drugs and the contribution of immune checkpoints in disease progression

|DSpasce-unipr|2019|0